Clinical Trial Update: Dose Finding Study of PB127 Ultrasound Contrast Agent in Healthy Volunteers and Patients With Coronary Artery Disease [Phase 2]

View source ↗

Summary

Phase 2 dose-finding study of PB127 ultrasound contrast agent was conducted in healthy volunteers and patients with coronary artery disease. The study status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• PB127 Ultrasound Contrast Agent

Snippet

Sponsor: Point Biomedical | Conditions: Healthy, Coronary Artery Disease | Phase 2 | Status: COMPLETED